Azithromycin Powder, For Suspension
FDA Label NDC 70771-1422

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Azithromycin (NDC 70771-1422). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1422-1

Azithromycin for oral suspension, 300 mg

100 mg/5 mL

Rx only

Azithromycin Oral Suspension (654b77ea 07ad 4747 Ac35 5a2eb41f4588 01)

Azithromycin Oral Suspension (654b77ea 07ad 4747 Ac35 5a2eb41f4588 01)

NDC 70771-1423-2

Azithromycin for oral suspension, 600 mg

200 mg/5 mL

Rx only

Azithromycin Oral Suspension (654b77ea 07ad 4747 Ac35 5a2eb41f4588 02)

Azithromycin Oral Suspension (654b77ea 07ad 4747 Ac35 5a2eb41f4588 02)

NDC 70771-1424-2

Azithromycin for oral suspension, 900 mg

200 mg/5 mL

Rx only

Azithromycin Oral Suspension (654b77ea 07ad 4747 Ac35 5a2eb41f4588 03)

Azithromycin Oral Suspension (654b77ea 07ad 4747 Ac35 5a2eb41f4588 03)

NDC 70771-1425-2

Azithromycin for oral suspension, 1200 mg

200 mg/5 mL

Rx only

Azithromycin Oral Suspension (654b77ea 07ad 4747 Ac35 5a2eb41f4588 04)

Azithromycin Oral Suspension (654b77ea 07ad 4747 Ac35 5a2eb41f4588 04)

* Please review the disclaimer below.